Lupin gets FDA green signal for Mandideep facility; shares rise
Lupin shares were in demand on Wednesday after the drug maker received an establishment inspection report (EIR) from the US Food and Drug Administration (FDA) for its manufacturing facility in Mandideep, Madhya Pradesh.
Lupin shares rose on Wednesday after the company received an EIR from the US regulator for its Mandideep facility in Madhyapradesh.